Linearis Ventures

Quebec City, QC
SeedSeries B+CVCA Member Directory 2026

Investment Thesis

Linearis Ventures ignites precision medicine by supporting early-stage discoveries at the intersection of AI and biomarker analysis. The fund focuses on metabolic disease innovation, including cancer and diabetes applications, backing scientist and technical founders developing deep-tech solutions from seed through Series B.

Focus Areas

Investment Stage
SeedSeries B+
Sectors
Healthcare/Life SciencesPrecision MedicineAIBiomarker Analysis

Investment Signals

GeographyCanada-focused
ProvincesQC
Revenue Stagepre-revenue ok
Impact MandateYes
Business Modelsdeep-tech, IP-licensing

Sample Portfolio Companies

Zilia

AUM & Sources

N/A
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →

Similar Funds

See incorrect information?

Help us keep this directory accurate and up to date.